Despite forecasted negative growth, Caribou Biosciences' P/S...

Despite forecasted negative growth, Caribou Biosciences' P/S ratio stays on par with the industry, signaling investor optimism. But, current high prices may not be long-lasting given the poor revenue outlook and the P/S ratio comparison.